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Abstract
Aims/hypothesis Lower birthweight (a marker of fetal under-
nutrition) is associated with higher risks of type 2 diabetes and
cardiovascular disease (CVD) and could explain ethnic differ-
ences in these diseases. We examined associations between
birthweight and risk markers for diabetes and CVD in UK-
resident white European, South Asian and black African-
Caribbean children.
Methods In a cross-sectional study of risk markers for
diabetes and CVD in 9- to 10-year-old children of
different ethnic origins, birthweight was obtained from
health records and/or parental recall. Associations
between birthweight and risk markers were estimated
using multilevel linear regression to account for cluster-
ing in children from the same school.
Results Key data were available for 3,744 (66%) singleton
study participants. In analyses adjusted for age, sex and eth-
nicity, birthweight was inversely associated with serum urate
and positively associated with systolic BP. After additional
height adjustment, lower birthweight (per 100 g) was associ-
ated with higher serum urate (0.52%; 95% CI 0.38, 0.66),
fasting serum insulin (0.41%; 95% CI 0.08, 0.74), HbA1c
(0.04%; 95% CI 0.00, 0.08), plasma glucose (0.06%; 95%
CI 0.02, 0.10) and serum triacylglycerol (0.30%; 95%CI 0.09,
0.51) but not with BP or blood cholesterol. Birthweight was
lower among children of South Asian (231 g lower; 95% CI
183, 280) and black African-Caribbean origin (81 g lower;
95% CI 30, 132). However, adjustment for birthweight had no
effect on ethnic differences in risk markers.
Conclusions/interpretation Birthweight was inversely associ-
ated with urate and with insulin and glycaemia after adjust-
ment for current height. Lower birthweight does not appear to
explain emerging ethnic difference in risk markers for
diabetes.
Keywords Birthweight . Cardiovascular disease .
Childhood . Ethnicity . Type 2 diabetes
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Introduction
Risks of adult chronic diseases, particularly type 2 diabetes
and cardiovascular disease (CVD), appear to originate in early
life, possibly before birth [1, 2]. Lower birthweight (a marker
of fetal undernutrition) has been associated with increased
risks of both type 2 diabetes [3] and CVD [4]. However, in
many countries, ethnic minority populations have higher risks
of type 2 diabetes and CVD and lower mean birthweights,
raising the possibility that lower birthweight may be an im-
portant determinant of ethnic differences in risks of these
diseases [5]. In the UK, South Asians have markedly higher
risks of type 2 diabetes, coronary heart disease and stroke
compared with white Europeans [6–8], while black African-
Caribbeans have higher risks of type 2 diabetes and stroke
[6–8]. These ethnic differences in type 2 diabetes and cardio-
vascular risks are already apparent in childhood [9, 10]. Both
South Asians and black African-Caribbeans in the UK have
lower mean birthweights and an increased prevalence of low
birthweight compared with white Europeans [11]. However,
the extent to which ethnic differences in birthweight can
account for emerging ethnic differences in type 2 diabetes
and CVD risks remains unknown.
We therefore examined the associations between
birthweight and risk markers for type 2 diabetes and CVD at
both individual and ethnic group levels in children of South
Asian, black African-Caribbean and white European origin in
the UK and examined the contribution of ethnic differences in
birthweight to ethnic differences in these risk markers.
Examining the associations between birth size and risk
markers in childhood poses important analytical challenges.
Childhood size is an important determinant of risk markers for
type 2 diabetes and CVD and is also related to size at birth.
Adjustment for current body size may affect estimates of
association between birth size and disease risk markers and
should attempt to estimate the longer term effect of
birthweight on disease risk [12, 13]; inappropriate adjustment
could be misleading [14]. Our analyses follow an earlier
approach [12] in distinguishing between two components of
child size, height and body fatness, which are differently
associated with risk markers over the life course [15].
Because variation in birthweight or in fetal growth rate (rep-
resented by birthweight adjusted for gestational age) could be
more important [3], we have analysed associations between
birthweight and risk markers both with and without adjust-
ment for gestational age.
Methods
Study design The Child Heart and Health Study in England
(CHASE) was a cross-sectional investigation of the cardio-
vascular and type 2 diabetes risk profiles of children aged 9–
10 years of white European, South Asian and black African-
Caribbean origin. Ethics approval was obtained from the
relevant research ethics committee. Study methods have been
published [9, 10, 16]. The study included 200 state primary
schools in London, Birmingham and Leicester, half with a
high prevalence of South Asian children (stratified by Indian,
Pakistani and Bangladeshi origin) and half with a high prev-
alence of black African-Caribbean children (stratified by
black African and black Caribbean origin). Written, informed
consent was obtained for all participants and maternal permis-
sion sought to allow access to maternal health record infor-
mation on the gestation and birth of the participant. Mothers
were also asked to recall the hospital of birth, the birthweight
of the child and whether the birth occurred on time, early or
late and (if so) by how much.
Survey measurements Three trained research nurses measured
participants between October 2004 and February 2007, each
measuring approximately one-third of children in each ethnic
group. Height and weight were measured and BMI calculated.
Fat mass was determined from right-sided arm-to-leg bioelec-
trical impedance, using the Bodystat 1500 bioelectrical im-
pedance monitor (Bodystat, Isle of Man); fat mass was de-
rived using ethnicity- and sex-specific equations for children
of this age group in the UK [17] and presented as a height-
standardised fat mass index [FMI; weight (kg)/height (m)5],
derived to be independent of height (r=−0.02) [17]. FMI was
preferred to BMI because of its greater validity in this multi-
ethnic population [17]. BP was measured twice in the right
arm using an Omron HEM-907 (Omron Electronics, Milton
Keynes, UK) [18] with an appropriate cuff size [16]. Mean
systolic and diastolic BP (two readings) were adjusted for
errors in BP measurement arising from use of different cuff
sizes using a previously validated method [19].
A blood sample was obtained after an overnight fast.
Children were asked not to eat on the morning of the exam-
ination; those who reported having eaten breakfast were ex-
cluded from analyses. Serum for an insulin assay was sepa-
rated and frozen on dry ice immediately after collection.
Samples were shipped to a central laboratory within 48 h.
Serum insulin, plasma glucose, HbA1c (measured in whole
blood), serum blood lipids and serum C-reactive protein as-
says have previously been reported [9, 10]. Serum urate was
assayed using an enzymatic method [20]. HOMA equations
[21] were used to calculate insulin resistance (HOMA-IR).
Ethnicity and socioeconomic status Participant ethnicity was
defined as previously described [10] using self-reported pa-
rental ethnicity, where available (66%), or parentally defined
child ethnic origin (33%), or using information on parental
and grand-parental birth place provided by the child, cross-
checked with observer assessment of ethnicity (1%). Four
broad ethnic categories were defined (‘white European’,
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‘South Asian’, ‘black African-Caribbean’, ‘other’), with a more
detailed ten-level ethnic categorisation used for adjustments
(white European, Indian, Pakistani, Bangladeshi, other South
Asian, other Asian, black African, black Caribbean, other black,
other). Parental occupation obtained from parents or children
was coded using the UK National Statistics Socioeconomic
Classification (NS-SEC) for the parent with the highest classifi-
cation (professional and managerial; intermediate; routine and
manual; economically inactive; unclassified) [22].
Birthweight and gestational age Maternal medical record
data on participant birthweight, gestational age and
singleton/twin status were sought from several sources includ-
ing: (1) the mother’s hospital records; (2) hospital birth regis-
ters; (3) the North West Thames maternity database 1988–
2000 for hospital births in the former North West Thames
region; (4) the Health and Social Care Information Centre for
all study children born in the UK with appropriate maternal
consent (provided by 92% of mothers). Data were selected
preferentially from sources (1) to (4); if no information was
obtained, maternal recall data were used when available.
Statistical methods Statistical analyses were performed using
STATA/SE software (Stata/SE 12 forWindows; StataCorp LP,
College Station, TX, USA). All outcome variables except
systolic and diastolic BP were positively skewed and a log
transformation (base e) was used. Birthweight was approxi-
mately normally distributed. Low birthweight was defined as
a birthweight <2.5 kg [23]. Associations between birthweight
and risk markers were examined, with birthweight fitted both
in fifths and as a continuous variable. Departure from linearity
was examined graphically (risk marker plotted against
birthweight in fifths) and tested for by comparing models
containing birthweight in fifths fitted either as a categorical
or continuous variable. Continuous associations between
birthweight and risk markers for type 2 diabetes and CVD
were quantified as percentage differences (or absolute differ-
ences for BP) in each risk marker for a 100 g increase in
birthweight using multilevel linear regressionmodels adjusted
for sex, age (in fourths), ethnic group (ten levels), socioeco-
nomic position (five levels) and a random effect to allow for
clustering of children within schools. The effects of additional
adjustment for childhood height and FMI were examined,
fitting these as continuous variables. Birthweight×height
and birthweight×FMI interactions were also examined. To
examine whether associations between birthweight and type
2 diabetes and CVD risk markers differed by sex or ethnic
group, birthweight×sex and birthweight×ethnic group inter-
action terms were fitted. The effects of adjustment for gesta-
tional age and parity and of excluding mothers with gestation-
al diabetes or parental recall of birthweight only on the asso-
ciations between birthweight and risk markers were examined
in sensitivity analyses.
Results
Of 8,641 children invited to participate, 5,887 (68%) took
part. Among 5,681 singleton children, 4,515 (79%) provided
a fasting blood sample and had complete risk marker mea-
surements; 3,744 (66%) also had data for birthweight, of
whom 90% were born in the UK. These included 1,845 boys
and 1,899 girls, 1,002 white Europeans, 1,025 South Asians,
863 black African-Caribbeans and 854 children of other eth-
nicity. Birthweight sources for these participants were hospital
maternity records (36.1%), hospital birth register (5.6%), the
North West Thames maternity database (9.1%), Health and
Social Care Information Centre data (35.5%) and parental
recall (13.7%).
Birthweight patterns by sex and ethnic group are shown in
Table 1 and birthweight patterns by ethnic subgroup are
shown in Table 1 of the electronic supplementary material
(ESM).Mean birthweight was 94 g higher in boys than in girls
( p<0.0001), although the prevalence of low birthweight
(<2.5 kg) was similar (8.0% and 8.3%, respectively). Mean
birthweight was lower in all ethnic minority groups, including
South Asians (particularly Indians) and black African-
Caribbean groups (particularly black Caribbeans), than in
white Europeans. Prevalence of low birthweight was higher
among South Asians and black African-Caribbeans than
among white Europeans. Birthweight was moderately corre-
lated with current childhood height (r=0.20; p<0.0001) but
was only weakly correlated with FMI (r=0.04; p=0.02).
Associations between birthweight and risk markers for type 2
diabetes and CVD in individuals The continuous associations
between birthweight and type 2 diabetes and CVD risk
markers are shown in Table 2. Height-adjusted associations
for fifths of birthweight are summarised graphically in ESM
Fig. 1. The associations between birthweight and risk markers
all appeared graded, with no evidence of U-shaped associa-
tions (tests for non-linearity, all p>0.05). In models including
adjustments for age, sex, ethnic subgroup and school, there
was an inverse association between birthweight and urate and
a positive association with systolic BP; there were no appre-
ciable associations of birthweight with insulin resistance (IR),
glycaemia or blood lipids (Table 2). After additional adjust-
ment for current childhood height, birthweight had a stronger
inverse association with urate and was also inversely associ-
ated with fasting insulin, HOMA-IR, HbA1c, fasting glucose
and triacylglycerol. In continuous associations, for each 100 g
lower birthweight, the largest percentage increases were ob-
served for urate, HOMA-IR and insulin. No consistent asso-
ciations were observed for C-reactive protein, LDL-cholester-
ol, HDL-cholesterol or BP. After separate adjustment for
current childhood FMI (but without height), birthweight
showed marginal inverse associations with triacylglycerol
and urate but not with other risk markers. Combined
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adjustment for height and FMI increased the magnitude of the
inverse associations observed after height adjustment between
birthweight and fasting insulin, HOMA-IR, HbA1c, fasting
glucose, urate and triacylglycerol. An inverse association
between birthweight and C-reactive protein also appeared
(Table 2).
The associations between birthweight and risk markers in
models adjusted for height are shown separately by sex and by
ethnic group with tests for interaction (ESM Table 2).
Associations between birthweight and IR makers were stron-
ger in girls compared with boys and in white Europeans
compared with other ethnic groups. None of the
birthweight–risk marker associations showed evidence of sta-
tistical interactions between birthweight and height or be-
tween birthweight and FMI (all p>0.05; ESM Table 2).
Associations between birthweight in fifths and risk markers
are shown in ESM Table 3 to allow for the possibility of non-
linearity in these associations. This showed similar patterns to
the continuous associations presented in Table 2.
Associations between birthweight and risk markers with
cumulative adjustments for gestational age and parity are
shown in ESM Table 4. Associations between birthweight
and fasting insulin, HOMA-IR and urate were little affected
by gestational age adjustment; the association with HbA1c was
strengthened and those with fasting glucose and triacylglyc-
erol were weakened by approximately one-third. Additional
Table 2 Associations between birthweight and risk markers for type 2
diabetes and CVD with additional adjustments for childhood height and
adiposity
Blood analyte and adjustment % Difference/difference in
outcome for a 100 g
increase in birthweight
(95% CI)
p value
Insulin, pmol/l
Standard 0.28 (−0.07, 0.65) 0.12
Standard+height −0.41 (−0.74, −0.08) 0.02
Standard+FMI −0.05 (−0.36, 0.27) 0.76
Standard+height+FMI −0.72 (−1.00, −0.43) <0.0001
HOMA-IR
Standard 0.24 (−0.11, 0.60) 0.19
Standard+height −0.44 (−0.76, −0.11) 0.01
Standard+FMI −0.09 (−0.40, 0.23) 0.60
Standard+height+FMI −0.74 (−1.02, −0.45) <0.0001
HbA1c, %
Standard −0.03 (−0.06, 0.01) 0.12
Standard+height −0.04 (−0.08, 0.00) 0.03
Standard+FMI −0.04 (−0.07, 0.00) 0.05
Standard+height+FMI −0.05 (−0.08, −0.01) 0.01
HbA1c, mmol/l
Standard −0.05 (−0.11, 0.02) 0.15
Standard+height −0.07 (−0.13, 0.00) 0.03
Standard+FMI −0.06 (−0.12, 0.00) 0.06
Standard+height+FMI −0.08 (−0.14, −0.02) 0.01
Glucose, mmol/l
Standard −0.03 (−0.08, 0.01) 0.16
Standard+height −0.06 (−0.10, −0.02) 0.01
Standard+FMI −0.04 (−0.08, 0.01) 0.10
Standard+height+FMI −0.06 (−0.11, −0.02) 0.004
Urate (mmol/l)
Standard −0.36 (−0.50, −0.22) <0.0001
Standard+height −0.52 (−0.66, −0.38) <0.0001
Standard+FMI −0.45 (−0.58, −0.32) <0.0001
Standard+height+FMI −0.61 (−0.74, −0.48) <0.0001
C-reactive protein, nmol/l
Standard 0.47 (−0.29, 1.29) 0.23
Standard+height −0.23 (−0.94, 0.55) 0.56
Standard+FMI −0.36 (−0.97, 0.29) 0.27
Standard+height+FMI −0.99 (−1.56, −0.37) 0.002
Triacylglycerol (mmol/l)
Standard −0.13 (−0.34, 0.08) 0.23
Standard+height −0.30 (−0.51, −0.09) 0.01
Standard+FMI −0.26 (−0.46, −0.06) 0.01
Standard+height+FMI −0.43 (−0.63, −0.23) <0.0001
HDL-cholesterol, mmol/l
Standard −0.07 (−0.19, 0.04) 0.22
Standard+height 0.04 (−0.08, 0.16) 0.53
Standard+FMI −0.01 (−0.12, 0.11) 0.89
Standard+height+FMI 0.10 (−0.01, 0.22) 0.08
Table 2 (continued)
Blood analyte and adjustment % Difference/difference in
outcome for a 100 g
increase in birthweight
(95% CI)
p value
LDL-cholesterol, mmol/l
Standard 0.07 (−0.07, 0.21) 0.34
Standard+height 0.12 (−0.02, 0.27) 0.10
Standard+FMI 0.04 (−0.10, 0.18) 0.61
Standard+height+FMI 0.09 (−0.05, 0.24) 0.22
Systolic BP, mmHga
Standard 0.07 (0.01, 0.13) 0.02
Standard+height −0.03 (−0.09, 0.03) 0.32
Standard+FMI 0.05 (−0.01, 0.11) 0.12
Standard+height+FMI −0.05 (−0.11, 0.00) 0.07
Diastolic BP, mmHga
Standard 0.02 (−0.03, 0.08) 0.43
Standard+height −0.02 (−0.07, 0.04) 0.55
Standard+FMI 0.00 (−0.05, 0.05) 0.96
Standard+height+FMI −0.04 (−0.09, 0.02) 0.18
Percentage differences in outcome are presented for log-transformed
variables (all except BP); standard adjustment is for sex, age (in fourths),
NS-SEC group, ethnic subgroup and a random effect for school
a Absolute differences in BP are presented
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adjustment for parity did not appreciably affect associations
between birthweight and risk markers. Exclusion of 94 par-
ticipants born to mothers with gestational diabetes or 512
participants for whom birthweight data were based on parental
recall (rather than medical records) had no material effect on
these associations (ESM Table 5).
Ethnic differences in risk markers for type 2 diabetes and
CVD: the contribution of birthweight Ethnic differences in
risk markers for type 2 diabetes and CVD in this study
population have previously been reported [9, 10]. Ethnic
patterns in risk markers in the 3,744 singleton children with
birthweight data are shown in Table 1 and ethnic differences in
risk markers for CVD are shown in Table 3 (South Asians–
white Europeans) and Table 4 (black African-Caribbeans–
white Europeans). Compared with white Europeans, South
Asians had similar mean age and height. Their mean FMI,
fasting insulin, HOMA-IR, HbA1c, fasting glucose, C-reactive
protein, triacylglycerol, LDL-cholesterol and diastolic BP
were higher; mean HDL-cholesterol was lower. Compared
with white Europeans, black African-Caribbeans were taller
and had a lower mean FMI. They had higher mean levels of
fasting insulin, HOMA-IR, HbA1c, HDL-cholesterol and dia-
stolic BP, and lower mean levels of fasting glucose, urate,
triacylglycerol and systolic BP.
The effects of birthweight adjustment on ethnic differences
in risk markers between South Asians, South Asian subgroups
(Indian, Pakistani, Bangladeshi) and white Europeans in
height-standardised models are shown in Table 3. In compar-
isons with white Europeans, the markedly higher mean levels
of fasting insulin, HOMA-IR, HbA1c, glucose, C-reactive
protein, triacylglycerol and diastolic BP among South
Asians were minimally affected by birthweight adjustment
(being reduced by between 14% for fasting glucose and 2%
for C-reactive protein); the lower HDL-cholesterol levels in
South Asians were little affected. Birthweight adjustment had
similarly little impact on the magnitude of ethnic differences
in the South Asian subgroups, including the larger differences
in fasting insulin, urate, triacylglycerol and HDL-cholesterol
for Bangladeshis.
The effects of birthweight adjustment on ethnic differences
in risk markers between black African-Caribbeans (and black
Africans and black Caribbeans separately) and white
Europeans in height–standardised models are shown in
Table 4. In comparison with white Europeans, the markedly
higher mean levels of fasting insulin, HOMA-IR, HbA1c and
HDL-cholesterol in black African-Caribbeans were largely
unaffected by birthweight adjustment; the lower mean levels
of urate, triacylglycerol and systolic BP were similarly little
affected by birthweight adjustment. Adjustment for
birthweight similarly had little impact on the magnitude of
ethnic differences in the separate black African-Caribbean
subgroups, including the larger differences in fasting insulin
in black Caribbeans and the lower urate, triacylglycerol and
systolic BP levels in black Africans. In parallel analyses
without height adjustment (ESM Tables 6 and 7 for South
Asians and black Africans, respectively), similar results were
observed; birthweight adjustment had very little effect on
ethnic differences in risk markers. Repeating these analyses
fitting birthweight as a dichotomous variable (<2.5 kg,
≥2.5 kg) did not materially affect the results (data available
from authors).
Discussion
In this multiethnic study of prepubertal children, birthweight
was associated with some risk markers for type 2 diabetes and
CVD, although these were in most cases dependent on adjust-
ment for childhood size (particularly height). In analyses
unadjusted for childhood size, birthweight was inversely as-
sociated with serum urate and positively associated with sys-
tolic BP but not notably related to other risk markers. After
adjustment for childhood height, birthweight was inversely
associated not only with urate but also with fasting insulin,
HOMA-IR, HbA1c, fasting glucose and triacylglycerol.
Further adjustment for FMI strengthened many of these
height-adjusted associations. The associations between
birthweight, fasting insulin and HOMA-IR tended to be stron-
ger in girls and in white Europeans; associations with other
risk markers were mostly consistent across sexes and ethnic
groups. The associations were little affected by gestational
age, parity adjustment or exclusion of mothers with gestation-
al diabetes. There were marked ethnic differences in type 2
diabetes risk markers, with IR being higher among South
Asians and to a lesser extent black African-Caribbeans com-
paredwith white Europeans, while mean birthweight was lower
among South Asians and to a lesser extent black African-
Caribbeans. However, adjustment for differences in birthweight
did not account for ethnic differences in risk markers.
Relation to previous studies In the present study, birthweight
was inversely associated with IR and its correlates (including
triacylglycerol and urate). This is consistent with the results of
most population-based studies including 250+ prepubertal
children [6, 12, 13, 24–26], though not all [27, 28]. As in
most studies reporting an inverse association between
birthweight and IR, this was only apparent after adjustment
for current size [13, 24]. In the present study, as in an earlier
report [12], adjustment for height alone produced the inverse
birthweight–IR association, although adjustment for body
fatness alone did not reveal the association. An inverse
birthweight–IR association has previously been reported in
white Europeans [12, 13], in Indians [24] and in African-
origin populations [26]. No previous studies have compared
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the strength of birthweight–IR associations among South
Asians and white Europeans, although in the Bogalusa Heart
Study this association was slightly stronger among African-
Americans than among whites [26]. The inverse association,
after adjustment for current size, between birthweight and
circulating glucose levels (both fasting glucose and HbA1c)
observed in the present study has been widely reported in
adults [3] but has been reported in only one previous study
in children [25], with a further study reporting an inverse
association for ponderal index at birth [28]. Several other
relevant studies reported null associations [13, 24, 27].
However, positive birthweight–glucose associations have
been reported in Aboriginal child populations [13, 29] as in
adults [30]. The inverse association detected in the present
study may reflect the greater size and statistical power of the
present study compared with previous investigations. The
inverse association observed between birthweight and circu-
lating urate (apparent without adjustment for height in the
present study) is consistent with several earlier reports [27,
31, 32]. Although those reports tended to emphasise the role
of urate in developing hypertension [31, 32], in the present
study urate was associated with fasting insulin (r=0.21) and
only weakly with systolic or diastolic BP (r=0.11 and 0.08,
respectively), although a large Mendelian randomisation
study suggested that urate had no causal role in the develop-
ment of type 2 diabetes [33]. Despite several previous reports
suggesting that birthweight is inversely associated with child-
hoodBP after adjustment for current size [34], we observed no
inverse associations between birthweight and BP in the pres-
ent study, even after adjustment for current size. The absence
of any appreciable association between birthweight and LDL-
cholesterol is consistent with previous systematic review ev-
idence based on studies both in children and adults [35].
Although fetal undernutrition could contribute to ethnic
differences in risks of type 2 diabetes and CVD (especially
the high risks in South Asians) [5], this is to our knowledge
the first study to examine the contribution of birthweight to
ethnic differences in relevant risk markers. The absence of an
appreciable contribution of birthweight (or the presence of
low birthweight, <2.5 kg) to South Asian/white European
differences in markers of IR (despite a mean difference of
~250 g in birthweight between these groups) is consistent with
earlier reports in adults suggesting that a 250 g difference in
birthweight would only explain a 7–10% difference in type 2
diabetes risk [3], rather than the three- to fourfold difference
actually observed [6].
Strengths and limitations Strengths of this study include its
large sample size and balanced representation of children of
South Asian (including Indian, Pakistani, Bangladeshi), black
African-Caribbean (including black African, black Caribbean)
and white European origin from three major UK cities; the
measurement of important early risk markers for type 2
diabetes (particularly fasting glucose, HbA1c and markers of
IR including fasting insulin, HOMA-IR and urate [36]; and
the measurement of important early risk markers for CVD
(particularly LDL-cholesterol and BP). Although the study
response rate was only moderate, mean birthweight levels
and low birthweight prevalences among the different ethnic
groups in the present study were similar to those in national
data [11], suggesting that the study population was substan-
tially representative for the key exposure studied. FMI derived
from bioelectrical impedance and used with validated
ethnicity- and sex-specific equations [17] provided a robust
marker of body fatness in this multiethnic population [17].
Although the device used to measure BP (Omron HEM-907)
has not been validated in children, validation studies in adults
showed that the performance of the instrument was similar at
different BP levels [18]. Several data sources were used to
obtain contemporaneously recorded birthweight data from
health records. Parental recall data (which showed very close
agreement with health record data in 1,779 participants with
birthweight data from both sources) were available for a
further 14% of participants. Study participants with
birthweight data (83%) had similar risk marker profiles to
those of participants without birthweight data. Birthweight
patterns observed among study participants (including both
sex and ethnic differences) corresponded closely with those
for the UK overall [11]. In analyses of associations between
birthweight, diabetes and cardiovascular risk, we explored the
impact of specific components of current body size and were
able to make adjustments for potential confounders including
gestational age, socioeconomic status, parity and gestational
diabetes. However, this study was not able to capture ethnic
differences in body composition at birth other than those in
birthweight; recent reports have suggested that South Asian
infants in the UK have higher fat mass and differences are not
well captured by birthweight [37].
Implications Our results suggest that lower birthweight is
associated with higher levels of IR and circulating glucose
concentrations in this multiethnic childhood population,
though not with cardiovascular risk markers. With the excep-
tion of urate, these associations appear to be dependent on
adjustment for current height (though not on current body
fatness, a measure which is completely independent of
height). Such adjusted models effectively attempt to estimate
the longer term effect of lower birthweight on disease risk
while standardising for current height [12], andmay reflect the
growth trajectories taken to reach current body size [38]. Such
standardisation for childhood height appears reasonable:
height is strongly positively associated with IR and its corre-
lates during childhood, but the association is attenuated, or
reversed, by early adult life [12, 13]. Conversely, body fatness
is positively associated with IR and its correlates in adulthood
as well as in childhood [39], and in the present study it did not
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appear to be a confounder in models unadjusted for height.
Thus, standardisation of birthweight–risk marker associations
for current body fatness may be inappropriate and represent
overadjustment [15]. The associations between birthweight,
IR and glycaemia, though varying by sex and ethnic group,
are graded, not appreciably altered by adjustment for observed
confounders and consistent with the findings of other studies,
suggesting that there may be an important underlying causal
association with potential implications for type 2 diabetes
prevention. Defining the strength of the underlying causal
associations is important for assessing both causality and the
preventive potential of birthweight modification. Based on the
observed associations, a potentially feasible increase in
birthweight (~100 g) could reduce IR by ~0.4% and glucose
concentrations by 0.04–0.06%. These associations are small;
substantially greater reductions could potentially be obtained
by moderate reductions in childhood body fatness [39] or
energy intake [40]. However, such interpretation depends on
the underlying causal association, as low birthweight could
denote a considerably stronger and potentially important as-
sociation between early nutrition and subsequent disease risk
[5, 12]. It is also possible that strategies to improve fetal
nutrition, for example through maternal nutritional supple-
mentation, could benefit offspring health independently of
birthweight [41].
Previous reports have raised the possibility that low
birthweight, as a marker of fetal undernutrition, could help
to explain ethnic differences in type 2 diabetes and cardiovas-
cular risk [5, 10]. However, the results of the present study
suggest that ethnic differences in birthweight do not make an
important contribution to explaining ethnic differences in IR
and glycaemia between South Asians, black African-
Caribbeans and white Europeans. This particularly reflects
the small sizes of the associations between birthweight, insulin
and glycaemia in individual participants, so that adjustment
for the observed ethnic differences in mean birthweight (more
than 200 g between South Asians and white Europeans) had
little effect on ethnic differences in IR and glycaemia.
However, this does not exclude the possibility that other
factors operating in utero or at birth, including maternal nutri-
tion and maternal glucose control [42] and body composition
at birth (e.g. body fatness [37]), could be important determi-
nants of ethnic differences in diabetes or cardiovascular risk.
However, in seeking the causes of high emerging type 2
diabetes risks among South Asians and black African-
Caribbeans in the UK, it will also be important to consider
the later influences of childhood overweight, nutrition (includ-
ing energy intake), physical activity and fitness [39, 40, 43].
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